So it’s a good thing there are plenty of cheap and safe alternatives out there.
Vitamin K2 is one that I mention a lot. And the results of a new clinical study do a fine job of illustrating why.
Researchers studied 244 healthy postmenopausal women for three years. During that time, the women received either 180 mcg of K2 or a placebo daily.
Assessments of vitamin K status, bone mineral density, bone strength, and vertebral fractures took place at the start of the study–and again after one, two, and three years of treatment.
Results showed that K2 supplementation significantly improved vitamin K status. It also slowed down declines in both bone strength and density, while minimizing losses in vertebral height. (Yes, you do actually get shorter as you get older–and this is why.)
I’d call that a slightly better bet than Boniva, wouldn’t you?
The supplement used in this study was a product called MenaQ7–the same brand of K2 that I recommend to all of my patients.
If you haven’t already, do your bones a favor and pick a bottle up today.
“Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.” Osteoporos Int. 2013 Mar 23. [Epub ahead of print]